Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Non Operating Income: 2018-2024

Historic Non Operating Income for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to $56.6 million.

  • Avidity Biosciences' Non Operating Income fell 19.01% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.7 million, marking a year-over-year increase of 41.78%. This contributed to the annual value of $56.6 million for FY2024, which is 142.25% up from last year.
  • Latest data reveals that Avidity Biosciences reported Non Operating Income of $56.6 million as of FY2024, which was up 142.25% from $23.4 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Non Operating Income registered a high of $56.6 million during FY2024, and its lowest value of -$78,000 during FY2020.
  • Over the past 3 years, Avidity Biosciences' median Non Operating Income value was $23.4 million (recorded in 2023), while the average stood at $28.3 million.
  • Data for Avidity Biosciences' Non Operating Income shows a peak YoY surged of 8,032.26% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Avidity Biosciences' Non Operating Income stood at -$78,000 in 2020, then increased by 20.51% to -$62,000 in 2021, then soared by 8,032.26% to $4.9 million in 2022, then surged by 375.36% to $23.4 million in 2023, then skyrocketed by 142.25% to $56.6 million in 2024.